Kathleen M. Wood

A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer's Disease

Justin R. Piro, Daniel I. Benjamin, James M. Duerr et al. · Cell Reports · 2012 · 225 citations · Full text

Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin.

Stuart A. Thompson, Shigeki Higashiyama, Kathleen M. Wood et al. · Journal of Biological Chemistry · 1994 · 153 citations · Full text

Human Growth, Cytoskeleton, Cell Growth +20

Concentration-Dependent Modulation of Amyloid-β in Vivo and in Vitro Using the γ-Secretase Inhibitor, LY-450139

Thomas A. Lanz, Michael J. Karmilowicz, Kathleen M. Wood et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 133 citations

Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity

Kelly R. Bales, Sharon O'Neill, Nikolay Pozdnyakov et al. · Brain · 2015 · 64 citations · Full text

Cerebral Amyloid Angiopathy, Immunology, Neurochemical Biomarkers +23

Pharmacodynamics and Pharmacokinetics of the γ-Secretase Inhibitor PF-3084014

Thomas A. Lanz, Kathleen M. Wood, K. Richter et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 50 citations